Home | Contact
     ISSN 2149-2042
     e-ISSN 2149-4606
 
 
 
Volume : 36 Issue : 1 Year : 2020



Current Issue Archive Popular Articles Ahead of Print




Index














Membership




Applications



 
Temozolamide treatment and pseudoprogression description accompanies radiotheraphy on high grade glioma [Medeniyet Med J]
Medeniyet Med J. 2010; 25(1): 43-47

Temozolamide treatment and pseudoprogression description accompanies radiotheraphy on high grade glioma

Erdoğan Ayan, Fatih Han Bölükbaşı, Ramazan Sarı, İlhan Elmacı
Goztepe Training and Research Hospital, Neurosurgery Clinic, Istanbul

High grade gliomas need serious follow up in post operative period. It might be necessary to re-operate due to tumor progression in this period. In addition, some changes because of radiotherapy and chemotherapy might act like tumor progression. This condition is called pseudoprogression and its management is different. Therefore pseudoprogression is a new condition that should be known and considered via following up high grade gliomas. Studies for this subject increase in literature. We aimed to explain this new condition with a case that we assumed as pseudoprogression having high degree glioma.

Keywords: High grade glioma, pseudoprogression, radiotherapy, temozolamide


Yüksek evreli gliomlarda radyoterapiye eşlik eden temozolamid tedavisi ve psödoprogresyon kavramı

Erdoğan Ayan, Fatih Han Bölükbaşı, Ramazan Sarı, İlhan Elmacı
Göztepe Eğitim ve Araştırma Hastanesi, Nöroşirurji Kliniği, İstanbul

Anahtar Kelimeler: Pseudoprogresyon, radyoterapi, temozolamid, yüksek gradeli gliom


Erdoğan Ayan, Fatih Han Bölükbaşı, Ramazan Sarı, İlhan Elmacı. Temozolamide treatment and pseudoprogression description accompanies radiotheraphy on high grade glioma. Medeniyet Med J. 2010; 25(1): 43-47

Corresponding Author: Erdoğan Ayan, Türkiye


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar





 

  Copyright © 2019 MEDJ All Rights Reserved